Brought to you by:
VAM 2025 abstract submission period set to open Nov. 6
Vascular surgeon-scientists may submit their research for presentation at the 2025 Vascular Annual Meeting (VAM) in June starting from Nov. 6 through Wednesday, Jan. 8, 2025. VAM research—both clinical and translational—is considered for presentation in several different forums that appeal…
SVS launches VascuLEARN
The Society for Vascular Surgery (SVS) online learning management system (LMS), now known as SVS VascuLEARN. The platform was formerly called SVS OnDemand. VascuLEARN hosts hours of educational content for vascular surgeons, trainees and allied health professionals. After logging in…
Survey of off-label treatment of complex repair pinpoints factors behind underreported outcomes data
The potential for cost and time to be key factors in low levels of outcomes data reporting emerged during a national survey of the off-label use of approved endovascular devices for complex aortic aneurysm repair. Grayson S. Pitcher, MD, an…
One-year STRIDE study data show ‘meaningful’ limb salvage, mortality and QoL outcomes
One-year outcomes from the STRIDE study of the Indigo aspiration thrombectomy system (Penumbra) for lower-extremity acute limb ischemia (ALI) showed target limb salvage and mortality rates of 88.5% and 12%, respectively. The data were revealed by Thomas Maldonado, MD, professor…
VAM 2024: Paper exploring stroke rates in arch TEVAR emerges as winner of Poster Competition
The 2024 Vascular Annual Meeting (VAM) in Chicago showcased emerging talent in vascular surgery through a moderated Poster Competition held over two days of the conference. This event provided a platform for research and recognized excellence among the next generation…
Patient selection may explain ‘counterintuitive’ relationship between carotid stenting volume and outcomes in new study
High stroke and death rates relating to carotid stenting in the Pacific Northwest may be driven by the selection of high-risk patients with less than 80% stenosis, and reducing the frequency of stenting in this high-risk group—along with better adherence…
TCAR and endarterectomy both ‘reasonable’ but stenting linked to worse outcomes in kidney disease patients
A study examining outcomes between different carotid revascularisation procedures has concluded that transcarotid artery revascularisation (TCAR) and carotid endarterectomy (CEA) both represent a “reasonable choice” in severe chronic kidney disease (CKD) and haemodialysis patients—but transfemoral carotid artery stenting (TF-CAS) appears more likely to result…
Linda Harris elected SVS vice president
The Society for Vascular Surgery (SVS) has announced Linda Harris, MD, as its next vice president, meaning that she enters the presidential line and will become SVS leader in 2026. The announcement was made during the SVS Annual Business Meeting,…
Young vascular surgeons on the PAD frontier: ‘This is the time to seize the day,’ 2024 Veith Lecturer declares
Huge opportunities abound for vascular surgeons to take a leadership role on the frontlines of a developing peripheral arterial disease (PAD) treatment crisis in the U.S., said Michael Conte, MD, as he gave the second annual Frank J. Veith Distinguished…
‘We are in this together’: SVS president set to issue call for vascular surgery unity amid tensions of modern medicine
SVS President Joseph Mills, MD, is set to issue a rallying call steeped in classical history and decades of collected vascular surgery wisdom in order to bring the specialty together for a common purpose: to overcome “unrest” and to drive…